Skip to main content
. 2022 Feb 14;32(6):530–542. doi: 10.1038/s41422-022-00627-9

Table 1.

Clinical characteristics for the SYSUCC melanoma cohort.

Total
(n = 34)
CXCL13TLS
(n = 15)
CXCL13+TLS
(n = 8)
CXCL13+TLS+
(n = 11)
P
Gender 0.6811
 Female 16 8 4 4
 Male 18 7 4 7
Age, y 0.2947
 <50 14 4 4 6
 ≥50 20 11 4 5
Stage 1
 T3 4 2 1 1
 T4 30 13 7 10